Azilect
Azilect

0.77
A generic medicine indicated for neurological conditions. Prevents the rapid breakdown of dopamine in the central nervous system to support motor control and improve neurotransmitter availability.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Rasagiline
Reference Brand
Rasagiline
Product Origin
Generic Alternative
Reference Manufacturer
Teva
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Monoamine Oxidase B (MAO-B) Inhibitor
Pharmacological Class
Antiparkinsonian Agent
Clinical Indications
Manufacturer Description
Developed to mitigate motor fluctuations to support muscular control and alleviate rigid parkinsonian movements.
Mechanism of Action
Selectively and irreversibly binds to MAO-B, preventing synaptic dopamine degradation and prolonging extracellular activity in neural pathways.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Pheochromocytoma, Hepatic impairment, Concurrent use of antidepressant medications
Severe Adverse Events
Hypertensive crisis — requires immediate medical attention, Serotonin syndrome — requires immediate medical attention
Common Side Effects
Headache, Nausea, Joint pain
Uncommon Side Effects
Dizziness, Insomnia, Postural hypotension
Drug Interactions
Antidepressants, Ciprofloxacin, Pseudoephedrine
Pregnancy Safety Warnings
TGA Category C: Limited clinical studies. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Azilect is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy Oncology Support AU - Bicalutamide Prostate Cancer Anti-Androgen